PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Jan-2025 IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy AccessWire
08-Jan-2025 The 2025 Black Book of Physician Practice Management Technology Released: A Competitive Intelligence Report AccessWire
08-Jan-2025 Ensysce Biosciences Issues Annual Shareholder Letter AccessWire
08-Jan-2025 Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership AccessWire
08-Jan-2025 Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd. AccessWire
08-Jan-2025 TriageLogic Launches TriageIntelligence(TM) and Releases Updated Nurse Triage Handbook AccessWire
08-Jan-2025 Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals AccessWire
08-Jan-2025 Doubling of production capacity at the manufacturing site in Malmö PolyPeptide Group
08-Jan-2025 Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference AccessWire
08-Jan-2025 Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000 AccessWire
08-Jan-2025 PhenQ Reviews: Legit Fat Burner Supplement or Scam Weight Loss Pills? AccessWire
07-Jan-2025 Lifeloc Technologies Secures $750,000 Financing to Support Growth and Innovation AccessWire
07-Jan-2025 OnePoint Patient Care Expands Services to PACE Programs Newswire
07-Jan-2025 Dr. Airica Steed Shares Vision for Transforming Healthcare on the American Journal of Healthcare Strategy Podcast AccessWire
07-Jan-2025 Evaluate Releases 2025 Preview for Pharma Market Evaluate
07-Jan-2025 Novartis gene therapy poised to expand SMA treatment landscape, says GlobalData GlobalData
07-Jan-2025 Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues Carterra
07-Jan-2025 Neuraxpharm to further grow branded business with the acquisition of two leading narcolepsy treatments, Provigil® and Nuvigil® Neuraxpharm
07-Jan-2025 4SC announces update relating to Resminostat’s (Kinselby) Marketing Authorisation Application 4SC
07-Jan-2025 Transplantable piezoelectric biomaterial offers new treatment potential for central nervous system injuries and neurodegenerative diseases University of Bath